Crystallization of human complement component C5

被引:3
|
作者
Discipio, RG
Jenner, L
Thirup, S
Sottrup-Jensen, L
Nyborg, J
Stura, E
机构
[1] La Jolla Inst Expt Med, La Jolla, CA 92037 USA
[2] Univ Aarhus, Dept Mol & Struct Biol, DK-8000 Aarhus C, Denmark
[3] CEA Saclay, Dept Prot Engn, F-91191 Gif Sur Yvette, France
关键词
D O I
10.1107/S0907444997015011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human complement component C5 has been crystallized using a low-salt batch technique. The crystals are large hexagonal bipyramids often larger than 1.5 mm. Although these crystals were grown in low salt (0.1 M NaCl), they are remarkably stable for at least 2 months at 281 K and they are not dissolved in aqueous buffers containing up to 2 M sodium chloride. The space group is P3(1)21 or P3(2)21, and the cell parameters were determined to be a = 144.9, b = 144.9, c = 243.1 Angstrom; alpha = 90 degrees, beta = 90, gamma = 120 degrees. At room temperature and cryo-temperatures the crystals diffract at best to 6 Angstrom using rotating-anode X-ray sources. Using synchrotron radiation with cryoprotection using 40%(nu/nu)(-) PEG 400 the resolution limit can be extended to 3.3 Angstrom. In both cases the crystals show significant anisotropy, with relatively weaker reflections at higher resolution in the a*b* plane.
引用
收藏
页码:643 / 646
页数:4
相关论文
共 50 条
  • [1] STUDIES ON CHEMICAL NATURE OF FIFTH COMPONENT OF HUMAN COMPLEMENT C5
    NILSSON, U
    HEYM, G
    FEDERATION PROCEEDINGS, 1969, 28 (02) : 818 - &
  • [2] BIOSYNTHESIS OF FIFTH COMPONENT OF COMPLEMENT (C5) BY HUMAN FETAL TISSUES
    COLTEN, HR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1973, 1 (03): : 346 - 352
  • [3] Activation of complement component C5 - Comparison of C5 convertases of the lectin pathway and the classical pathway of complement
    Rawal, Nenoo
    Rajagopalan, Rema
    Salvi, Veena P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (12) : 7853 - 7863
  • [4] Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5
    Latuszek, Adrianna
    Liu, Yashu
    Olsen, Olav
    Foster, Randi
    Cao, Marc
    Lovric, Irena
    Yuan, Ming
    Liu, Nina
    Chen, Henry
    Zhang, Qian
    Xiao, Hui
    Springer, Carola
    Ehrlich, George
    Kamat, Vishal
    Rafique, Ashique
    Hu, Ying
    Krueger, Pamela
    Huang, Tammy
    Poueymirou, William
    Babb, Robert
    Rosconi, Michael P.
    Retter, Marc W.
    Chen, Gang
    Morton, Lori
    Zambrowicz, Brian
    Cao, Jingtai
    Romano, Carmelo
    Olson, William C.
    PLOS ONE, 2020, 15 (05):
  • [5] ASSIGNMENT OF HUMAN-COMPLEMENT COMPONENT C5 TO CHROMOSOME-9
    JEREMIAH, SJ
    WEST, LF
    DAVIS, MB
    POVEY, S
    CARRITT, B
    FEY, G
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 634 - 634
  • [6] Immunological and genetic characterization of deficiency of the component C5 of the human complement system
    Aguilar-Ramirez, P.
    Florido, M. P. C.
    Reis, E. S.
    Kierstman, D.
    Costa-Carvalho, B. T.
    Isaac, L.
    MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3918 - 3918
  • [7] Complement component C5 is not involved in scrapie pathogenesis
    Mabbott, NA
    Bruce, ME
    IMMUNOBIOLOGY, 2004, 209 (07) : 545 - 549
  • [9] Evaluation of anti-human complement component 5 antibody in humanized C5 mice
    Latuszek, Adrianna
    Liu, Yashu
    Foster, Randi
    Lovric, Irena
    Yuan, Ming
    Chen, Henry
    Hu, Ying
    Krueger, Pamela
    Huang, Tammy
    Poueymirou, William
    Yancopoulos, George
    Zambrowicz, Brian
    Cao, Jingtai
    Romano, Carl
    Olson, William
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [10] EPITOPES OF THE 5TH COMPONENT OF COMPLEMENT (C5) ARE EXPRESSED ON HUMAN-MONOCYTES
    ZIERZ, R
    BAUMGARTEN, H
    SCHULZE, M
    GOTZE, O
    IMMUNOBIOLOGY, 1985, 170 (1-2) : 115 - 116